IL18 and diabetes mellitus: The current study shows that Lf decreased diabetes-induced inflammation by inhibiting the TLR-4-NF-κB axis with subsequent reduction in serum proinflammatory cytokines; IL-1β, IL-6, and IL-18, in diabetic children.